XAIR (Beyond Air, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by XAIR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-31 | DANIEL J MOORHEAD | Chief Financial Officer | Buy | — | — |
| 2026-07-31 | Robert Scott Goodman | Chief Executive Officer | Buy | — | — |
| 2026-01-06 | DANIEL J MOORHEAD | Chief Financial Officer | A | — | — |
| 2025-11-24 | Michael A. Gaul | Chief Operating Officer | MIXED | — | — |
| 2025-11-24 | Yoori Lee | Director | MIXED | — | — |
| 2025-11-07 | Robert Carey | Director | MIXED | — | — |
| 2025-11-07 | Robert Carey | Director | MIXED | — | — |
| 2025-11-06 | Steven A. Lisi | CEO and Chairman of the Board | MIXED | — | — |
| 2025-11-06 | Steven A. Lisi | CEO and Chairman of the Board | MIXED | — | — |
| 2025-11-06 | Robert Scott Goodman | Director | MIXED | — | — |
| 2025-11-06 | Douglas Quinton Larson | Chief Financial Officer | MIXED | — | — |
| 2025-11-06 | Erick Lucera | Director | MIXED | — | — |
| 2025-11-06 | William P Forbes | Director | MIXED | — | — |
| 2025-08-18 | Robert Scott Goodman | Director | A | — | — |
| 2025-07-23 | Steven A. Lisi | CEO and Chairman of the Board | Buy | — | — |
| 2025-03-28 | Yoori Lee | Director | A | — | — |
| 2025-03-28 | Robert Carey | Director | A | — | — |
| 2025-03-28 | William P Forbes | Director | A | — | — |
| 2025-03-28 | Steven A. Lisi | CEO and Chairman of the Board | A | — | — |
| 2025-03-28 | Erick Lucera | Director | A | — | — |
| 2025-03-28 | Douglas Quinton Larson | Chief Financial Officer | A | — | — |
| 2025-03-28 | Michael A. Gaul | Chief Operating Officer | A | — | — |
| 2025-03-17 | Robert Carey | Director | Buy | — | — |
| 2025-02-21 | Michael A. Gaul | Chief Operating Officer | Buy | — | — |
| 2024-11-26 | Yoori Lee | Director | MIXED | — | — |
| 2024-11-26 | William P Forbes | Director | MIXED | — | — |
| 2024-11-26 | Robert Carey | Director | MIXED | — | — |
| 2024-11-26 | Douglas Quinton Larson | Chief Financial Officer | MIXED | — | — |
| 2024-11-26 | Erick Lucera | Director | MIXED | — | — |
| 2024-11-26 | Steven A. Lisi | CEO and Chairman of the Board | MIXED | — | — |
| 2024-11-26 | RON BENTSUR | Director | MIXED | — | — |
| 2024-11-26 | Michael A. Gaul | Chief Operating Officer | MIXED | — | — |
| 2024-10-01 | Steven A. Lisi | CEO and Chairman of the Board | Buy | — | — |
| 2024-10-01 | Robert Carey | Director | Buy | — | — |
| 2024-08-19 | Steven A. Lisi | CEO and Chairman of the Board | Buy | — | — |
| 2024-08-15 | Robert Carey | Director | Buy | — | — |
| 2024-08-15 | Erick Lucera | Director | Buy | — | — |
| 2024-08-15 | Steven A. Lisi | CEO and Chairman of the Board | Buy | — | — |
| 2024-03-21 | Steven A. Lisi | CEO and Chairman of the Board | A | — | — |
| 2024-03-21 | Douglas Quinton Larson | Chief Financial Officer | A | — | — |
| 2024-03-21 | Robert Carey | Director | A | — | — |
| 2024-03-21 | Erick Lucera | Director | A | — | — |
| 2024-03-21 | William P Forbes | Director | A | — | — |
| 2024-03-21 | Michael A. Gaul | Chief Operating Officer | A | — | — |
| 2024-03-21 | Douglas Quinton Larson | Chief Financial Officer | A | — | — |
| 2024-03-21 | Steven A. Lisi | CEO and Chairman of the Board | A | — | — |
| 2024-03-21 | Amir Avniel | Chief Business Officer | A | — | — |
| 2024-03-21 | Yoori Lee | Director | A | — | — |
| 2024-03-21 | Robert Carey | Director | A | — | — |
| 2024-03-21 | RON BENTSUR | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | CEO and Chairman of the Board | 166,371 | — |
| — | Chief Executive Officer | 34,822 | — |
| — | Director | 13,859 | — |
| — | Chief Financial Officer | 4,340 | — |
| — | Chief Business Officer | 1,714 | — |
| — | Director | 362 | — |
| — | Chief Operating Officer | 235 | — |
| — | Chief Medical Officer | 116 | — |
| — | Director | 109 | — |
| — | Chief Financial Officer | 102 | — |
| — | Chief Financial Officer | 69 | — |
| — | Director | 37 | — |
| — | Director | 32 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XAIR quote page; the site-wide leaderboard is on the insider transactions hub.